GTCbio Announces Its 2nd Annual Oncology Biomarkers Conference

Main Category: Conferences
Also Included In: Cancer / Oncology;  Biology / Biochemistry
Article Date: 12 Dec 2008 - 6:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


GTCbio just announced its 2nd Annual Oncology Biomarkers Conference taking place on January 19-20, 2009 in Miami, Florida.

The conference will take attendees through "The Life Cycle of a Cancer Biomarker"; examining the path from the identification of a candidate biomarker, development through validation, onto the clinic to be able to identify unmet needs and spark new discoveries back in the laboratory. This unique organization of the sessions will allow attendees to view the interdependency of the entire process.

Sessions include:
The Birth of a Biomarker - Pre-clinical,
Growing pains - Early Clinical Design,
Adolescence - Clinical Validation,
Maturity - In the Clinic,
and Going Full circle - Lessons Learned from the Clinic.

The conference features prominent leaders from all across the field of cancer research to cover new and innovative techniques for biomarker detection and validation.

Keynote and featured presentations will be given by Dr. Samir Hanash, Program Head of the Fred Hutchinson Cancer Research Center, Dr. Christopher Foster, Professor, University of Liverpool, and Dr. Garret Hampton, Executive Director of Molecular and Medical Sciences at Celgene San Diego. Other speakers from NIH, FDA, Merck, Abbott laboratories, Amgen, Roche, MD Anderson Cancer Center and more, will present on the 19th and 20th.

For more information on attending, presenting a poster, or sponsoring, please visit http://gtcbio.com/conferenceDetails.aspx?id=142.

ABOUT GTCbio

GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.

GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.

Source:
GTCBIO
434 W. Foothill Blvd. Monrovia,
CA 91016
Tel: (626) 256-6405
fax: (626) 256-6460
email: infogtcbio@gtcbio.com

Article adapted by Medical News Today from original press release.
Visit our conferences section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
raniah@gtcbio.com. "GTCbio Announces Its 2nd Annual Oncology Biomarkers Conference." Medical News Today. MediLexicon, Intl., 12 Dec. 2008. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/132868.php>

APA
raniah@gtcbio.com. (2008, December 12). "GTCbio Announces Its 2nd Annual Oncology Biomarkers Conference." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/132868.php.

Please note: If no author information is provided, the source is cited instead.


Conferences

Most Popular Articles



Follow Our Conferences News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Conferences Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »